Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference86 articles.
1. Genetic evidence for a tumor suppressor role of HIF-2alpha;Acker;Cancer Cell,2005
2. Cancer of the Kidney and Renal Pelvis – SEER Stat Fact Sheets [Internet];Anon,2016
3. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008
4. Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling;Bhatt;Mol. Cancer Ther.,2010
5. Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation;Bohonowych;BMC Cancer,2011
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort;European Journal of Cancer;2024-01
2. Augmented anti-cancer effect of hypoxia-inducible factor 2α (HIF2α)- targeting PT2385 delivered in α-synuclein-AuNP microcapsules for clear cell renal carcinoma mouse model;Journal of Drug Delivery Science and Technology;2024-01
3. Evolution of the HIF targeted therapy in clear cell renal cell carcinoma;Cancer Treatment Reviews;2023-12
4. Hypoxia-inducible factor 2α protein and mRNA expression correlate with histomorphological features in clear cell renal cell carcinoma;Pathology - Research and Practice;2023-11
5. A Comprehensive Description of Hypoxia-inducible Factor 2α Inhibitors as Anticancer Agents: A Mini-review;Current Medicinal Chemistry;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3